Bibliography (12):

1. https://journals.sagepub.com/doi/full/10.1177/1098612X16660441

2. The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats

3. Safety and efficacy assessment of a GLP-1 mimetic: insulin glargine combination for treatment of feline diabetes mellitus

4. https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15915

5. A Once-Monthly GLP-1 Receptor Agonist for Treatment of Diabetic Cats

6. Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats

7. https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12917-024-04051-6/MediaObjects/12917_2024_4051_Fig1_HTML.png

8. https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12917-024-04051-6/MediaObjects/12917_2024_4051_Fig3_HTML.png

9. Wikipedia Bibliography:

   1. https://en.wikipedia.org/wiki/Glucagon-like_peptide-1_receptor_agonists  :

      https://en.wikipedia.org/wiki/Glucagon-like_peptide-1_receptor_agonists

   2. Exenatide

   3. Cat

   4. Confidence interval